Sejong, South Korea

A-hyeon Lee

This inventor holds 1 USPTO granted patent. Top assignee: Metaimmunetech Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: A-hyeon Lee. Retrieved from https://idiyas.com/inventor/a-hyeon-lee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: A-hyeon Lee and Lens-Free Analysis of Natural Killer Cell Activity

Introduction

A-hyeon Lee is an inventor associated with Metaimmunetech Inc. in Sejong, South Korea. His patent work includes an imaging-based approach for analyzing the activity of natural killer (NK) cells.

Latest Patents

Lee is named on one patent, 1 patent: “Apparatus for Analyzing Natural Killer Cell Activity Using Lens-Free Shadow Imaging Technique, and Method Therefor.” The invention uses a lens-free shadow image and a dedicated algorithm to assess NK cell activity. The algorithm detects image parameters, such as peak-to-peak distances, the width of secondary maxima, and related statistical measures, and uses them to analyze cell activity.

Career Highlights

Lee’s listed work connects him with Metaimmunetech Inc. and focuses on applying lens-free imaging and image analysis to NK cell assessment. The patent describes a method that derives measurable shadow features from images rather than relying on a conventional lens-based imaging setup.

Collaborations

Lee’s listed coworkers include Sungkyu Seo and Inha Lee.

Conclusion

A-hyeon Lee’s patent presents a lens-free imaging approach that uses shadow-image parameters to analyze natural killer cell activity.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…